TK
Therapeutic Areas
Interrad Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SecurAcath Pediatric Indication | Prevention of non-cuffed central venous catheter dislodgement in pediatric patients | Clinical Evidence |
| SecurAcath CLABSI Reduction | Reduction of Central Line-Associated Bloodstream Infection risk | Clinical Evidence |
| Health Economic Validation | Demonstration of cost savings vs. standard securement | Commercial |